TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Ribozyme Sweden AB
Closing information (x1000 NOK)
Closing information | 2023/08 | 2022/08 | 2021/08 |
Turnover |
29
|
17
|
0 |
Financial expenses |
18
|
17
|
18 |
Earnings before taxes |
-10
|
-18
|
-33 |
EBITDA |
8
|
-2
|
-14 |
Total assets |
1,440
|
1,350
|
1,469 |
Current assets |
56
|
45
|
41 |
Current liabilities |
888
|
820
|
869 |
Equity capital |
552
|
530
|
600 |
- share capital |
98
|
92
|
101 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Solvency |
38.3%
|
39.3%
|
40.8% |
Turnover per employee |
29
|
17
|
0 |
Profit as a percentage of turnover |
-34.5%
|
-105.9% | |
Return on assets (ROA) |
0.6%
|
-0.1%
|
-1.0% |
Current ratio |
6.3%
|
5.5%
|
4.7% |
Return on equity (ROE) |
-1.8%
|
-3.4%
|
-5.5% |
Change turnover |
12
|
17
|
0 |
Change turnover % | 67% | ||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.